Nephro-Urology Monthly

Published by: Kowsar

Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men

Mohammadreza Nowroozi 1 , Mohsen Ayati 1 , Hassan Jamshidian 1 , Amir Arbab 1 , Hamidreza Ghorbani 1 , * , Erfan Amini 1 , Hassan Hakima 2 , Sohrab Salehi 3 and Alireza Ghadian 4
Authors Information
1 Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
2 Farhangian University, Qazvin, IR Iran
3 Department of Urology, Qazvin University of Medical Sciences, Qazvin, IR Iran
4 Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: March 01, 2015, 7 (2); e26752
  • Published Online: March 20, 2015
  • Article Type: Research Article
  • Received: January 11, 2015
  • Accepted: February 1, 2015
  • DOI: 10.5812/numonthly.26752

To Cite: Nowroozi M, Ayati M, Jamshidian H, Arbab A, Ghorbani H, et al. Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men, Nephro-Urol Mon. 2015 ; 7(2):e26752. doi: 10.5812/numonthly.26752.

Copyright © 2015, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Matsuda T, Saika K. Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol. 2009; 39(7): 468-9[DOI][PubMed]
  • 2. Chen CS, Wang SS, Li JR, Cheng CL, Yang CR, Chen WM, et al. PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy. J Chin Med Assoc. 2011; 74(12): 552-5[DOI][PubMed]
  • 3. Matsuda T, Saika K. Comparison of time trends in prostate cancer incidence (1973 1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV VIII. Jpn J Clin Oncol. 2007; 37(7): 556-7[DOI][PubMed]
  • 4. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991; 145(5): 907-23[PubMed]
  • 5. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 1992; 147(3 Pt 2): 817-21[PubMed]
  • 6. Mettlin C, Littrup PJ, Kane RA, Murphy GP, Lee F, Chesley A, et al. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project. Cancer. 1994; 74(5): 1615-20[PubMed]
  • 7. Hammerer PG, McNeal JE, Stamey TA. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol. 1995; 153(1): 111-4[DOI][PubMed]
  • 8. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology. 1994; 43(5): 601-6[PubMed]
  • 9. Dadkhah F, Safarinejad MR, Amini E, Lashay AR, Baghayee A. Utility of prostate specific antigen density and free to total prostate specific antigen ratio for detecting prostate cancer in Iranian men: a prospective study of 187 cases. Curr Urol. 2010; 4(1): 1-5[DOI]
  • 10. Sung DJ, Cho SB, Kim YH, Oh YW, Lee NJ, Kim JH, et al. Comparison of prostate-specific antigen adjusted for transition zone volume versus prostate-specific antigen density in predicting prostate cancer by transrectal ultrasonography. J Ultrasound Med. 2004; 23(5): 615-22[PubMed]
  • 11. Lam JS, Cheung YK, Benson MC, Goluboff ET. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men. J Urol. 2003; 170(2 Pt 1): 451-6[DOI][PubMed]
  • 12. Zheng XY, Xie LP, Wang YY, Ding W, Yang K, Shen HF, et al. The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL. J Cancer Res Clin Oncol. 2008; 134(11): 1207-10[DOI][PubMed]
  • 13. Stephan C, Stroebel G, Heinau M, Lenz A, Roemer A, Lein M, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. Cancer. 2005; 104(5): 993-1003[DOI][PubMed]
  • 14. Aslan G, Irer B, Kefi A, Celebi I, Yorukoglu K, Esen A. The value of PSA, free-to-total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer. Int Urol Nephrol. 2005; 37(3): 511-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments